{
  "Q0": "BRCA1/BRCA2 genetic testing",
  "Q1": "Yes",
  "Q2": "Not specified",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4_sub1": "Yes",
  "Q4_sub2": "NCCN",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9_sub": "Yes",
  "Q10": "No",
  "Q10_sub": "Risk Assessment",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14_sub": "81162, 81163, 81164, 81165, 81166, 81167",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "According to the policy, the following steps must be followed: 1) The patient's provider must document the family history with special attention to breast and ovarian cancer, including prior pathology reports, physician's notes, and a formal 3-generation pedigree. 2) Genetic counseling regarding the appropriateness of testing should be performed by the PCP or an authorized specialist. 3) Complete the 'Aetna Breast and Ovarian Cancer Susceptibility Gene Prior Authorization Form' confirming the basis for high-risk status. 4) Submit the form to the requesting Laboratory along with the Laboratory's test requisition form. 5) The blood specimen should not be tested until confirmation of coverage is received and the test is precertified. 6) Both the Laboratory and Aetna will confirm member eligibility before performing the test.",
  "match": true
}